A Study Of Daratumumab, Low-Dose Oral Dexamethasone and Cyclophosphamide With Or Without Pomalidomide
Clinical trial NCT03215524 · COMPLETED
Trial details
- NCT number
- NCT03215524
- Sponsor
- Canadian Myeloma Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-25
- Primary completion
- 2022-06-24
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.